340B

Feldesman Partners Gabriel García and Jacki Leifer will present at the 2025 Annual Conference and Health Care Provider Retreat, co-hosted by the New Mexico Primary Care Association and New Mexico Health Resources, [...]

Feldesman Partner Steve Kuperberg will speak at the 340B Grantees Spring Conference, taking place from May 29 – 30 in Kansas City, MO. On May 30, Mr. Kuperberg will present “340B Legal Focus: [...]

Key Challenges Still Loom for Covered Entities On Monday, May 12, the White House issued an Executive Order (EO) aimed at addressing  prescription drug prices. The EO opens with a remarkable [...]

On April 15, President Trump signed an Executive Order reviving a previous directive to reduce the cost of insulin and injectable epinephrine for low income individuals. The Executive Order instructs the Secretary [...]

“Eternal vigilance is the price of liberty.”  – quote attributed to Thomas Jefferson and John Philpot Curran Over the past two years, nearly three dozen states have considered legislation requiring drug manufacturers [...]

The new second term Trump Administration, barely a month old, has stirred controversy through a lightning-fast review of federal spending, in some cases attempting to freeze trillions of dollars in already-appropriated federal [...]

As a new Congress and Administration begin a dizzying series of initiatives, health centers and others participating in the federal 340B drug discount statute understandably crave predictions regarding 340B’s future. Not only [...]

Feldesman Partner Steve Kuperberg was quoted in the 340B Report’s December 23, 2024, edition in the aftermath of a federal judge’s ruling against a 340B contract pharmacy law in West Virginia. Following [...]

Federally qualified health centers (FQHCs) and other federal grantees participating in the federal 340B drug discount statute face potentially devastating, practical effects on their ability to serve vulnerable patient populations from a [...]

Most government agencies charged with enforcement responsibilities seek to publicize their enforcement efforts and provide transparency into their standards. Doing so simultaneously increases the reach of those enforcement efforts while also promoting [...]